Centrum Badań Klinicznych PI-House

What Centrum Badań Klinicznych PI-House does

Centrum Badań Klinicznych PI-House sp. z o.o. is a specialized clinical research site headquartered in Gdańsk, Poland, founded in 2011 and operating as a wholly-owned subsidiary of Penta Hospitals Polska since mid-2024. The company conducts Phase II/III (and adjacent) clinical trials for pharmaceutical companies and Contract Research Organizations across seven therapeutic areas: adult and child/adolescent psychiatry, neurology, adult and pediatric dermatology, metabolic disorders, and rheumatology. It is positioned as one of Poland's most experienced CNS clinical trial sites, with 250+ completed protocols and approximately 60 active research projects annually executed by a 35-person staff of specialist physicians, clinical trial coordinators, nurses, pharmacists, and psychotherapists.

The core physical and protocol infrastructure includes a 2-station polysomnography sleep laboratory, secure Investigational Medicinal Product (IMP) storage zones for controlled substances, dedicated therapeutic space for psychedelic-assisted trials, a 24-hour participant stay zone, and continuous temperature monitoring systems, all operated under GCP-compliant procedures. PI-House is recognized as the first private site in Poland authorized to conduct clinical trials with controlled substances including psychedelics. In January 2026, the center extended operations via a branch at ul. Wyspiańskiego 25 in Gdańsk, opened in partnership with NeuroVitalis clinic to add multiple sclerosis and Parkinson's disease indications. A Virtual Trial Capable Certification supports hybrid/decentralized study conduct.

Revenue is generated through two streams: (1) sponsored clinical trial fees paid by pharmaceutical companies and CROs for protocol conduct, patient enrollment, data collection, and regulatory compliance under professional services agreements; and (2) outpatient consultation fees paid out-of-pocket at the affiliated mental health, diabetology, health promotion, geriatric, and sleep disorders clinics (priced 50-330 PLN per visit). Patient recruitment for trials is conducted via a four-step direct enrollment process through website forms, phone inquiries, and physician referrals. Cited partnerships include Worldwide Clinical Trials, NeuroVitalis, the Polish Diabetes Society, the Polish Psychedelic Society, Jagiellonian University, and the Higher School of Health in Gdańsk.

Name

Centrum Badań Klinicznych PI-House

Legal name

Centrum Badań Klinicznych PI-House sp. z o.o.

Website

https://pihouse.pl

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Centrum Badań Klinicznych PI-House is a Gdańsk-based, GCP-compliant clinical research site founded in 2011, conducting Phase II/III trials in CNS, dermatology, metabolic, and rheumatology indications for pharmaceutical sponsors and CROs, and operating Poland's first private psychedelic trial facility under the Penta Hospitals Polska network.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAGACAG

Clinical Trial Monitoring Support (On-site/Remote)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLALAEAB

Psychiatry & Medication Management Platforms

Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms

SECONDARYHLAGAEAK

Point-of-Care & Decentralized Trial Testing Services

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

• Clinical trial services
• CNS clinical research
• Psychiatric clinical trials
• Psychedelic research site
• Outpatient mental health

Headquarters

HQ city

Gdansk

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Trial Conduct Services: PI-House generates revenue by conducting clinical trials on behalf of pharmaceutical companies and Contract Research Organizations (CROs). The company receives compensation for study conduct, patient enrollment, data collection, and regulatory compliance services under sponsored clinical research agreements.
2. Clinic Patient Services: Revenue from private medical consultations at the affiliated outpatient clinic, including psychiatric, diabetes, health promotion, geriatric, and psychology services. Paid out-of-pocket by patients at established fee schedules.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Centrum Badań Klinicznych PI-House is a specialized clinical research center that conducts sponsored clinical trials for pharmaceutical companies and Contract Research Organizations (CROs) across therapeutic areas including psychiatry, neurology, dermatology, metabolic disorders, and rheumatology. The center also operates affiliated outpatient clinics providing mental health, diabetology, sleep disorders, geriatric, and health promotion consultations. It is recognized as the first private site in Poland equipped to run clinical trials with controlled substances including psychedelics.

Product overview

Centrum Badań Klinicznych PI-House operates as a clinical research center offering a unified portfolio of clinical trial services and outpatient medical clinics. The core offering consists of clinical trials spanning seven therapeutic areas (psychiatry for adults and children/youth, neurology, dermatology for adults and children/youth, metabolic disorders, and rheumatology). The center supplements its research activities with multiple outpatient clinic modules: Mental Health Clinic, Diabetes Clinic, Sleep Disorders Clinic, Geriatric Clinic, and Health Promotion Clinic. Specialized infrastructure includes a Sleep Laboratory with polysomnography stations and a dedicated space for psychedelic clinical trials. In January 2026, the center expanded with a NeuroVitalis branch for neurology research. The facility also provides 24-hour stay zones for participant monitoring during trials.

Differentiator

Problem solved

Functional benefit

Brands

• PI-House Clinic: Outpatient clinic offering consultations in mental health, diabetology, health promotion, geriatrics, and sleep disorders.

Products and services

• Clinical Trials (Badania Kliniczne) Sponsored clinical trial conduct services covering psychiatry (adults and children/youth), neurology, dermatology (adults and children/youth), metabolic disorders, and rheumatology. The center enrolls patients, collects data, and delivers regulatory-compliant study conduct for pharmaceutical sponsors and CROs.
• Mental Health Clinic (Poradnia Zdrowia Psychicznego)
• Diabetes Clinic (Poradnia Diabetologiczna)
• Sleep Disorders Clinic (Poradnia Zaburzeń Snu)
• Geriatric Clinic (Poradnia Geriatryczna)
• Health Promotion Clinic (Poradnia Promocji Zdrowia)
• Sleep Laboratory (Laboratorium Snu)
• Specialized Psychedelic Research Space (Specjalistyczna Przestrzeń do Badań Psychodelicznych)

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• NeuroVitaliscoreStrategic or Co-development PartnerCollaboration since January 2026 to expand neurology, psychiatry, and pain treatment capabilities. New branch at ul. Wyspiańskiego 25 in Gdańsk enables clinical projects in new indications such as multiple sclerosis and Parkinson's disease.
• Polskie Towarzystwo Diabetyków (Polish Diabetes Society)minorOthersPartnership with the Polish Diabetes Society for diabetes-related clinical trials and patient outreach.
• Polskie Towarzystwo Psychodeliczne (Polish Psychedelic Society)minorOthersPartnership for psychedelic clinical trial research collaboration and knowledge exchange.
• Uniwersytet Jagielloński (Jagiellonian University)minorStrategic or Co-development PartnerAcademic partnership for clinical research collaboration.
• Wyższa Szkoła Zdrowia w Gdańsku (Higher School of Health in Gdańsk)minorStrategic or Co-development PartnerPartnership with local healthcare educational institution for research collaboration.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Worldwide Clinical Trials: Global mid-sized CRO with significant CNS trial operations and a stated partnership with PI-House; competes for the same CNS protocols that PI-House conducts as a site, making it both a partner and a directly comparable trial-services peer.
• Velocity Clinical Research: US-headquartered dedicated clinical trial site network operating multi-therapeutic sites; most structurally similar pure-play site network to PI-House in terms of running trials on behalf of pharma sponsors with therapeutic-area specialization.
• Flourish Research: Multi-site clinical research organization with therapeutic-area depth similar to PI-House's CNS/dermatology/metabolic focus; competes directly for the same sponsor study placements at scale.
• Clínical Trials Centre Clinipace Worldwide: Mid-sized global CRO that operates site-management capabilities and competes for CNS and multi-therapeutic trials in similar customer profiles (mid-sized pharma and biotech sponsors).

Broad incumbents

• Penta Hospitals Polska (network level): Parent network running seven research centers across Poland with 500+ research programs since 2005; PI-House operates within this network, making the broader Penta sites directly comparable as fellow Polish trial sites with shared back office.
• Syneos Health: Large global CRO with dedicated clinical site solutions and CNS therapeutic experience; competes for the same biopharma sponsor contracts that PI-House serves, but at a much broader portfolio scale.
• IQVIA: Largest global CRO with extensive site network and CNS/dermatology/endocrine therapeutic depth; relevant incumbent peer because it both runs trials directly and aggregates sites similar to PI-House.
• ICON plc: Global CRO with site-management services and broad therapeutic coverage including CNS and dermatology; relevant for the same biopharma sponsor pipeline as PI-House.
• Parexel International: Large global CRO with deep CNS clinical operations footprint and hybrid/decentralized trial capabilities; serves many of the same pharma sponsors that engage PI-House as a site.

Emerging players

• Science 37: Decentralized clinical trial technology and operations company; relevant emerging peer because PI-House holds a Virtual Trial Capable certification, intersecting with Science 37's decentralized model for CNS trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/cbkpihouse
• LinkedInlinkedin.com/company/pihouse

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centrum Badań Klinicznych PI-House